PUBLICATIONS

20172016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
2006 | 2005 | 200420032002


2017

    • Ganesh T, Estrada M, Yeger H, Duffin J, Cheng HL. “A non-invasive MR imaging approach for assessment of real-time microcirculation dynamics,” Scientific Reports 7(1), 7468, 2017.

 


2016

    • Loai S, Haedicke IE, Mirzaei Z, Simmons C, Zhang XA, Cheng HL. “Positive-contrast cellular MRI of mouse embryonic stem cells for tissue regeneration using a highly efficient T1 MRI contrast agent,” Journal of Magnetic Resonance Imaging 44(6), 1456-1463, 2016.
    • Haedicke IE, Li T, Zhu YL, Martinez F, Hamilton AM, Murrell DH, Nofiele JT, Cheng HL, Scholl TJ, Foster PJ, Zhang XA. “An enzyme-activatable and cell-permeable Mn(III)-porphyrin as a highly efficient T(1) MRI contrast agent for cell labeling,” Chemical Science 7(7), 4308-4317, 2016.
    • Ganesh T, Estrada M, Duffin J, Cheng HL. “T2* and T1 assessment of abdominal tissue response to graded hypoxia and hypercapnia using a controlled gas mixing circuit for small animals,” Journal of Magnetic Resonance Imaging 44(2), 305-316, 2016.

2015

    • Ganesh T, Mokhtari RB, Alhamami M, Yeger H, Cheng HL. “Manganese-enhanced MRI of minimally gadolinium-enhancing breast tumors,” Journal of Magnetic Resonance Imaging 41(3), 806-813, 2015.
    • Nofiele JT, Haedicke IE, Zhu YL, Zhang XA, Cheng HL. “Gadolinium-free extracellular MR contrast agent for tumor imaging,” Journal of Magnetic Resonance Imaging 41(2), 397-403, 2015.
    • Amirabadi A, Vidarsson L, Miller E, Sussman MS, Patil K, Gahunia H, Peel SA, Zhong A, Weiss R, Detzler G, Cheng HL, Moineddin R, Doria AS. “USPIO-related T1 and T2 mapping MRI of cartilage in a rabbit model of blood-induced arthritis: a pilot study,” Haemophilia 21(1), e59-69, 2015.

2014

    • Cheng HL, Haedicke IE, Cheng W, Nofiele JT, Zhang XA. “Gadolinium-free T1 contrast agents for MRI: tunable pharmacokinetics of a new class of manganese porphyrins,” Journal of Magnetic Resonance Imaging 40(6), 1474-1480, 2014.
    • Nasui OC, Chan MW, Nathanael G, Crawley A, Miller E, Belik J, Cheng HL, Kassner A, Rayner T, Weiss R, Detzler G, Zhong A, Moineddin R, Jong R, Rogers M, Doria AS. “Physiologic characterization of inflammatory arthritis in a rabbit model with BOLD and DCE MRI at 1.5 Tesla,” European Radiology 24(11), 2766-2778, 2014.
    • Mokhtari RB, Nofiele JT, Islam SS, Yeger H, Cheng HL. “Abstract 1220: Investigation of the biological properties of human breast cancer in a nude rat model,” Cancer Res 74(19 Supplement), 1220-1220, 2014.
    • Mokhtari RB, Islam SS, Baluch N, Aitken K, Kumar S, Cheng M, Yazdanpanah M, Adeli K, Zhou Y, Cutz E, Yeger H. “Abstract 3133: The anti-tumor effects of acetazolamide and sulforaphane on bronchial carcinoids: Preclinical modeling and mechanism,” Cancer Res 74(19 Supplement), 3133-3133, 2014.
    • Nofiele JT, Cheng W, Haedicke IE, Ganesh T, Zhang XA, Cheng HL. “Ultrashort echo time magnetic resonance imaging of the lung using a high-relaxivity T1 blood-pool contrast agent,” Molecular Imaging 13(8), 7290201400027, 2014.
    • Alhamami M, Mokhtari RB, Ganesh T, Nofiele JT, Yeger H, Cheng HL. “Manganese-enhanced magnetic resonance imaging for early detection and characterization of breast cancers,” Molecular Imaging 13(7), 7290201400021, 2014
    • Cohen M, Syme C, Deforest M, Wells G, Detzler G, Cheng HL, McCrindle B, Hanley A, Hamilton J. “Ectopic fat in youth: the contribution of hepatic and pancreatic fat to metabolic disturbances,” Obesity 22(5), 1280-1286, 2014
    • Nofiele JT, Cheng HL. “Establishment of a lung metastatic breast tumor xenograft model in nude rats,” PLoS One 9(5), e97950, 2014.
    • Clique H, Cheng HL, Marie PY, Felblinger J, Beaumont M. “3D myocardial T(1) mapping at 3T using variable flip angle method: Pilot study,” Magnetic Resonance in Medicine 71(2), 823-829, 2014.
    • Cheng W, Ganesh T, Martinez F, Lam J, Yoon H, Macgregor RB Jr, Scholl TJ, *Cheng HL, Zhang XA. “Binding of a dimeric manganese porphyrin to serum albumin: towards a gadolinium-free blood-pool T1 MRI contrast agent,” Journal of Biological Inorganic Chemistry 19(2), 229-235, 2014.
    • Cheng W, Haedicke IE, Nofiele J, Martinez F, Beera K, Scholl TJ, *Cheng HL, Zhang XA. “Complementary strategies for developing Gd-free high-field T1 MRI contrast agents based on Mn(III) porphyrins,” Journal of Medicinal Chemistry 57(2), 516-520, 2014.
    • Nofiele JT, Czarnota GJ, Cheng HL. “Noninvasive manganese-enhanced magnetic resonance imaging for early detection of breast cancer metastatic potential,” Molecular Imaging, 13(1), 7290201300071, 2014.

2013

    • Nofiele JT, Cheng HL. “Ultrashort echo time for improved positive-contrast manganese-enhanced MRI of cancer,” PLoS One 8(3), e58617, 2013.
    • Narayanam S, de Oliveira V, Krishnamurthy G, Bekhit E, Sertic M, Cheng HL, Connolly BL. “Fate, complications and MRI implications of retention anchor suture placed during gastrostomy in children,” Pediatric Radiology 43(8), 1009-1016, 2013.

2012

    • Cheng HL, Stikov N, Ghugre NR, Wright GA. “Practical medical applications of quantitative MR relaxometry,” Journal of Magnetic Resonance Imaging 36(4), 805-824, 2012.
    • Loai Y, Ganesh T, Cheng HL. “Concurrent dual contrast for cellular magnetic resonance imaging using gadolinium oxide and iron oxide nanoparticles,” International Journal of Molecular Imaging 2012, 230942, 2012.
    • Cheng HL. “Effect of hyperoxia and hypercapnia on tissue oxygen and perfusion response in the normal liver and kidney,” PLoS One 7(7), e40485, 2012.
    • Cheng HL, Holowka S, Moineddin R, Odama I. “Liver iron overload assessment by T2* magnetic resonance imaging in pediatric patients: an accuracy and reproducibility study,” American Journal of Hematology 87(4), 435-437, 2012.
    • Loai Y, Sakib N, Janik R, Foltz WD, Cheng HL. “Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla,” Molecular Imaging 11(2), 166-175, 2012.
    • Cheng HL, Loai Y, Farhat WA. “Monitoring tissue development in acellular matrix-based regeneration for bladder tissue engineering: multiexponential diffusion and T2* for improved specificity,” NMR in Biomedicine 25(3), 418-426, 2012.

2011

    • Winter JD, Estrada M, Cheng HL. “Normal tissue quantitative T1 and T2* MRI relaxation time responses to hypercapnic and hyperoxic gases,” Academic Radiology 18(9), 1159-1167, 2011.
    • Winter JD, St. Lawrence KS, Cheng HL. “Quantification of renal perfusion: Comparison of arterial spin labeling and dynamic contrast-enhanced MRI,” Journal of Magnetic Resonance Imaging 34(3), 608-615, 2011.
    • Nossin-Manor R, Chung AD, Morris D, Soares-Fernandes JP, Thomas B, Cheng HL, Whyte HE, Taylor MJ, Sled JG, Shroff MM. “Optimized T1- and T2-weighted volumetric brain imaging as a diagnostic tool in very preterm neonates,” Pediatric Radiology 41(6):702-710, 2011.
    • Winter JD, Akens MK, Cheng HL. “Quantitative MRI assessment of VX2 tumour oxygenation changes in response to hyperoxia and hypercapnia,” Physics in Medicine and Biology 56(5), 1225-1242, 2011.
    • Kershaw LE, Cheng HL. “A general dual-bolus approach for quantitative DCE-MRI,” Magnetic Resonance Imaging 29(2), 160-166, 2011.

2010

    • Kershaw LE, Cheng HL. “Temporal resolution and SNR requirements for accurate DCE-MRI data analysis using the AATH model,” Magnetic Resonance in Medicine 64(6), 1772-1780, 2010.
    • Studler U, White LM, Andreisek G, Luu S, Cheng HL, Sussman MS. “Impact of motion on T1 mapping acquired with inversion recovery fast spin echo and rapid spoiled gradient recalled-echo pulse sequences for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) in volunteers,” Journal of Magnetic Resonance Imaging 32(2), 394-398, 2010.
    • Cheng HL, Loai Y, Beaumont M, Farhat WA. “The acellular matrix (ACM) for bladder tissue engineering: A quantitative magnetic resonance imaging study,” Magnetic Resonance in Medicine 64(2), 341-348, 2010.
    • Sussman MS, Vidarsson L, Pauly JM, Cheng HL. “A technique for rapid single-echo spin-echo T2 mapping,” Magnetic Resonance in Medicine 64(2), 536-545, 2010.
    • Cheng HL, Islam SS, Loai Y, Antoon R, Beaumont M, Farhat WA. “Quantitative magnetic resonance imaging assessment of matrix development in cell-seeded natural urinary bladder smooth muscle tissue-engineered constructs,” Tissue Engineering Part C Methods 16(4), 643-651, 2010.
    • Beaumont M, DuVal MG, Loai Y, Farhat WA, Sandor GK, Cheng HL. “Monitoring angiogenesis in soft-tissue engineered constructs for calvarium bone regeneration: an in vivo longitudinal DCE-MRI study,” NMR in Biomedicine 23(1), 48-55, 2010.

2009

    • Cheng HL. “Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach,” Journal of Magnetic Resonance Imaging 30(4), 864-872, 2009.
    • Andreisek G, White LM, Yang Y, Robinson E, Cheng HL, Sussman MS. “Delayed gadolinium-enhanced MR imaging of articular cartilage: three-dimensional T1 mapping with variable flip angles and B1 correction” Radiology 252(3), 865-873, 2009.
    • Beaumont M, Odame I, Babyn PS, Vidarsson L, Kirby-Allen M, Cheng HL. “Accurate liver T2 measurement of iron overload: a simulations investigation and in vivo study,” Journal of Magnetic Resonance Imaging 30(2), 313-320, 2009.

2008

    • Cheng HL, Haider MA, Dill-Macky MJ, Sweet JM, Trachtenberg J, Gertner MR. “MRI and contrast-enhanced ultrasound monitoring of prostate microwave focal thermal therapy: an in vivo canine study,” Journal of Magnetic Resonance Imaging 28(1), 136-143, 2008.
    • Cheng HL. “Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI,” Journal of Magnetic Resonance Imaging 28(3), 736-743, 2008.
    • Chavhan GB, Babyn PS, Jankharia BG, Cheng HL, Shroff MM. “Steady-state MR imaging sequences: physics, classification, and clinical applications,” Radiographics 28(4), 1147-1160, 2008.

2007

    • Cheng HL. “Dynamic contrast-enhanced MRI in oncology drug development,” Current Clinical Pharmacology 2(2), 111-122, 2007.
    • Cheng HL. “T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1-weighted DCE-MRI,” Journal of Magnetic Resonance Imaging 25(5), 1073-1078, 2007.
    • Cheng HL, Wallis C, Shou Z, Farhat WA. “Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights,” Journal of Magnetic Resonance Imaging 25 (1), 137-145, 2007.

2006

    • Cartwright L, Farhat WA, Sherman C, Chen J, Babyn P, Yeger H, Cheng HL. “Dynamic contrast-enhanced MRI to quantify VEGF-enhanced tissue-engineered bladder graft neovascularization: pilot study,” Journal of Biomedical Materials Research Part A 77(2), 390-395, 2006.
    • Cheng HL, Wright GA. “Rapid high-resolution T(1) mapping by variable flip angles: Accurate and precise measurements in the presence of radiofrequency field inhomogeneity,” Magnetic Resonance in Medicine 55(3), 566-574, 2006.

2005

    • Cheng HL, Chen J, Babyn PS, Farhat WA. “Dynamic Gd-DTPA enhanced MRI as a surrogate marker of angiogenesis in tissue-engineered bladder constructs: a feasibility study in rabbits,” Journal of Magnetic Resonance Imaging 21(4), 415-423, 2005.

2004

    • Cheng HL, Purcell CM, Bilbao JM, Plewes DB. “Usefulness of contrast kinetics for predicting and monitoring tissue changes in muscle following thermal therapy in long survival studies,” Journal of Magnetic Resonance Imaging 19(3), 329-341, 2004.

2003

    • Cheng HL, Purcell CM, Bilbao JM, Plewes DB. “Prediction of subtle thermal histopathological change using a novel analysis of Gd-DTPA kinetics,” Journal of Magnetic Resonance Imaging 18(5), 585-598, 2003.

2002

    • Cheng HL, Plewes DB. “Tissue thermal conductivity by magnetic resonance thermometry and focused ultrasound heating,” Journal of Magnetic Resonance Imaging 16(5), 598-609, 2002.

For Complete list please visit: http://www.ncbi.nlm.nih.gov/pubmed/?term=hai-ling+Cheng